Cantel Medical revenue was $918.16 m in FY, 2019
Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $93.26 m | $97.3 m | $97.24 m | $99.68 m | $106.36 m | $105.01 m | $118.27 m | $119.04 m | $120.06 m | $136.81 m | $135.43 m | $141.51 m | $153.78 m | $158.27 m | $173.7 m | $187.73 m | $184.82 m | $192.11 m | $212.77 m | $425.8 m | $643.07 m | $225.59 m | $224.54 m | $228.55 m | $257.25 m | $256.94 m | $207.69 m | $297.03 m | $261.1 m | $277.49 m |
Cantel Medical revenue breakdown by business segment: 53.7% from Endoscopy, 22.8% from Water Purification and Filtration, 19.4% from Healthcare Disposables and 4.1% from Other
Cantel Medical revenue breakdown by geographic segment: 77.9% from United States, 5.3% from Asia/Pacific, 12.4% from Europe/Africa/Middle East and 4.4% from Other
FY, 2014 | FY, 2017 | FY, 2016 | FY, 2015 | |
---|---|---|---|---|
Endoscopy | $190.44 m | $398.77 m | $341.75 m | $248.65 m |
Water Purification and Filtration | $159.51 m | $169.45 m | $177.67 m | $173.83 m |
Dialysis | $30.93 m | $30.48 m | $32.75 m | $31.24 m |
Healthcare Disposables | $101.81 m | $144.46 m | $112.58 m | $106.92 m |
Other | $6.07 m | $4.36 m |
FY, 2017 | FY, 2016 | |
---|---|---|
Latin America/South America | $7.14 m | $7 m |
United States | $599.66 m | $515.06 m |
Asia/Pacific | $40.96 m | $33.37 m |
Canada | $26.65 m | $20.98 m |
Europe/Africa/Middle East | $95.75 m | $88.36 m |
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.